Safety of mRNA vaccination for COVID-19 in children with polyethylene glycol (PEG)-asparaginase allergy.

Doyle, Rebecca; Melo, Mariana; Teoh, Cindy; Wen, Sophie; Willcocks, Sophie

Doyle, Rebecca; Melo, Mariana; Teoh, Cindy; Wen, Sophie; Willcocks, Sophie.

Afiliação

Doyle R; Children's Health Queensland Hospital and Health Service, South Brisbane, Australia.
Melo M; University of Queensland, School of Nursing, Midwifery and Social Work, St Lucia, Australia.
Teoh C; Children's Health Queensland Hospital and Health Service, South Brisbane, Australia.
Wen S; Children's Health Queensland Hospital and Health Service, South Brisbane, Australia.
Willcocks S; Children's Health Queensland Hospital and Health Service, South Brisbane, Australia.

Pediatr Allergy Immunol ; 34(3): e13939, 2023 03.

Article em En | MEDLINE | ID: mdl-36974643

Assuntos

COVID-19; Hipersensibilidade a Drogas; Hipersensibilidade; Criança; Humanos; Asparaginase/efeitos adversos; COVID-19/prevenção & controle; Polietilenoglicóis/efeitos adversos

Palavras-chave

COVID-19; PEG-asparaginase; hypersensitivity; vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipersensibilidade a Drogas / COVID-19 / Hipersensibilidade Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google